2021 US Molecular Diagnostics Market Assessment: Supplier Shares and Sales Forecasts by Test and Application
This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Contains 42 pages and 5 tables
Contains 42 pages and 5 tables
BUSINESS ENVIRONMENT
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
MARKET STRUCTURE
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
MARKET STRUCTURE
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLES
Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays
Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays
More Publications
US Diagnostics Market 2021: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts by Test, Competitive Intelligence, Opportunities for Suppliers
US$ 5,400.00
September 2017
101 pages
2017-2021 US Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
US$ 6,120.00
March 2017
997 pages
2017 US Hospital Coagulation Testing Market
US$ 5,670.00
March 2017
411 pages
2016-2020 US Diagnostics Market: Blood Banking, Cancer, Coagulation, Flow Cytometry, Hematology, Immunodiagnostics, Microbiology, Molecular Diagnostics-Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts for 300 Tests
US$ 4,320.00
March 2016
101 pages
U.S. 8 Respiratory Diseases, 2019-2023: Supplier Shares and Country Segment Forecasts, 2019-2023
US$ 2,450.00
July 2019
283 pages